Skip to main content
Figure 3 | BMC Cancer

Figure 3

From: The influence of the combined treatment with Vadimezan (ASA404) and taxol on the growth of U251 glioblastoma xenografts

Figure 3

Color change of xenografts 32 h after the treatment with taxol [B], 8 h after the treatment with ASA404 [C] or 32 h after the treatment with taxol plus a ASA404 during the last 8 h [D]. Xenograft [A] represents an untreated control. Treatment with ASA404 as a sole agent or in combination with taxol most probably caused change of permeability and selective disruption of blood vessels within tumors followed by hemorrhagic necrosis.

Back to article page